| Jarrett K Johnston, APRN | |
|
7601 Pioneers Blvd, Lincoln, NE 68506-4675 | |
| (402) 484-6677 | |
| (402) 484-4815 |
| Full Name | Jarrett K Johnston |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 7601 Pioneers Blvd, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003585852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 113794 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Medical Imaging Llc | 0840265773 | 36 |
| Radiology Associates Pc | 5698735181 | 30 |
News Archive
Genes for many may be widely associated with determining certain traits and characteristics. Now a study co-led by John H. Martin of The CUNY School of Medicine at The City College of New York is demonstrating that they could also influence neural motor skills.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 7 days ago
| Entity Name | Fillmore County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508956467 PECOS PAC ID: 9638144942 Enrollment ID: O20040831000463 |
News Archive
Genes for many may be widely associated with determining certain traits and characteristics. Now a study co-led by John H. Martin of The CUNY School of Medicine at The City College of New York is demonstrating that they could also influence neural motor skills.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 7 days ago
| Entity Name | Advanced Medical Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437116936 PECOS PAC ID: 0840265773 Enrollment ID: O20040901001407 |
News Archive
Genes for many may be widely associated with determining certain traits and characteristics. Now a study co-led by John H. Martin of The CUNY School of Medicine at The City College of New York is demonstrating that they could also influence neural motor skills.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 7 days ago
| Entity Name | Radiology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548227036 PECOS PAC ID: 5698735181 Enrollment ID: O20041019000491 |
News Archive
Genes for many may be widely associated with determining certain traits and characteristics. Now a study co-led by John H. Martin of The CUNY School of Medicine at The City College of New York is demonstrating that they could also influence neural motor skills.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 7 days ago
| Entity Name | Fillmore County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689769382 PECOS PAC ID: 9638144942 Enrollment ID: O20070115000244 |
News Archive
Genes for many may be widely associated with determining certain traits and characteristics. Now a study co-led by John H. Martin of The CUNY School of Medicine at The City College of New York is demonstrating that they could also influence neural motor skills.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jarrett K Johnston, APRN 7601 Pioneers Blvd, Lincoln, NE 68506-4675 Ph: (402) 484-6677 | Jarrett K Johnston, APRN 7601 Pioneers Blvd, Lincoln, NE 68506-4675 Ph: (402) 484-6677 |
News Archive
Genes for many may be widely associated with determining certain traits and characteristics. Now a study co-led by John H. Martin of The CUNY School of Medicine at The City College of New York is demonstrating that they could also influence neural motor skills.
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
Midwest Employers Casualty Company (MECC), the leading workers' compensation excess insurance company that helps clients to manage their Total Cost of Risk, today announced the unveiling of its Safety Cornerstones Express program to Self-Insured Groups (SIGs).
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 7 days ago
Megan Elizabeth Heusinkvelt, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7001 A St Ste 210, Lincoln, NE 68510 Phone: 402-488-4022 Fax: 402-488-4113 | |
Lindsey Ann Vlcan, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-7619 | |
Mary Monica Snow, RN APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 220 Lyncrest Dr, Lincoln, NE 68510 Phone: 402-434-3370 Fax: 402-489-0731 | |
Kayla Hallock, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3740 N 27th St Ste 1, Lincoln, NE 68521 Phone: 402-423-0396 | |
Jonna Rae Lynch, DNP, NNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1600 S 48th St, Lincoln, NE 68506 Phone: 402-481-7327 | |
Linda Kroeger, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2611 S 70th St, Lincoln, NE 68506 Phone: 402-423-4200 Fax: 402-423-4201 |